CPIX
Cumberland Pharmaceuticals Inc.

2,606
Mkt Cap
$45.77M
Volume
131,049.00
52W High
$6.27
52W Low
$1.85
PE Ratio
-16.00
CPIX Fundamentals
Price
$3.01
Prev Close
$3.06
Open
$3.06
50D MA
$4.03
Beta
0.64
Avg. Volume
182,964.78
EPS (Annual)
-$0.1909
P/B
1.84
Rev/Employee
$478,725.07
$57.52
Loading...
Loading...
News
all
press releases
Cumberland Pharmaceuticals Launches New Sancuso Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting
Cumberland Pharmaceuticals Launches New Sancuso Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting Cumberland Pharmaceuticals Launches New Sancuso Website Featuring...
PR Newswire·8h ago
News Placeholder
More News
News Placeholder
Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales
CPIX's Q4 revenues jump 31%, while loss narrows year over year as sales of Vibativ, Sancuso and new product Talicia boosted its performance.
Zacks·7d ago
News Placeholder
H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) DelveInsight
H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight H. pylori Infections Market in the 6MM to Observe...
PR Newswire·13d ago
News Placeholder
Cumberland Pharmaceuticals Q4 Earnings Call Highlights
Cumberland Pharmaceuticals (NASDAQ:CPIX) reported fourth-quarter and full-year 2025 results and provided a business update during its earnings call, highlighting revenue growth across its portfolio...
MarketBeat·14d ago
News Placeholder
CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA
CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA PR Newswire NASHVILLE, Tenn., Feb. 25, 2026 NASHVILLE, Tenn., Feb. 25, 2026...
PR Newswire·20d ago
News Placeholder
Joint U.S. Commercialization of RedHill's Talicia Commences
Joint U.S. Commercialization of RedHill's Talicia Commences Joint U.S. Commercialization of RedHill's Talicia Commences PR Newswire RALEIGH, N.C. and TEL-AVIV, Israel, Feb. 25, 2026 The full sales...
PR Newswire·20d ago
News Placeholder
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE PR Newswire NASHVILLE...
PR Newswire·21d ago
News Placeholder
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above 200 Day Moving Average - Should You Sell?
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Cross Above 200 Day Moving Average - Time to Sell...
MarketBeat·29d ago
News Placeholder
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above 200-Day Moving Average - Here's Why
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving Average - Here's Why...
MarketBeat·1mo ago
<
1
2
...
>

Latest CPIX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.